See more : Solar Company S.A. (SOL.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Aveanna Healthcare Holdings Inc. (AVAH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aveanna Healthcare Holdings Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Great-West Lifeco Inc. (GWO.TO) Income Statement Analysis – Financial Results
- E-Starco. Co. Ltd (015020.KS) Income Statement Analysis – Financial Results
- Cassiar Gold Corp. (CGLCF) Income Statement Analysis – Financial Results
- Albany International Corp. (AIN) Income Statement Analysis – Financial Results
- Barnes Group Inc. (B) Income Statement Analysis – Financial Results
Aveanna Healthcare Holdings Inc. (AVAH)
About Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.90B | 1.79B | 1.68B | 1.50B | 1.38B | 1.25B |
| Cost of Revenue | 1.30B | 1.23B | 1.14B | 1.04B | 964.81M | 859.35M |
| Gross Profit | 595.43M | 553.23M | 542.40M | 454.52M | 419.25M | 394.32M |
| Gross Profit Ratio | 31.42% | 30.95% | 32.31% | 30.40% | 30.29% | 31.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 443.13M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Selling & Marketing | 8.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 473.30M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Other Expenses | 114.06M | 36.11M | 20.21M | 17.94M | 16.64M | -13.74M |
| Operating Expenses | 587.36M | 520.06M | 447.98M | 372.71M | 357.64M | 339.71M |
| Cost & Expenses | 1.89B | 1.75B | 1.58B | 1.41B | 1.32B | 1.20B |
| Interest Income | 327.00K | 679.00K | 253.00K | 345.00K | 207.00K | 594.00K |
| Interest Expense | 153.25M | 99.94M | 68.93M | 82.98M | 92.30M | 75.54M |
| Depreciation & Amortization | 30.10M | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
| EBITDA | 44.35M | -517.28M | -9.26M | 22.13M | 44.28M | 96.11M |
| EBITDA Ratio | 2.34% | 3.64% | 7.83% | 7.50% | 5.19% | 4.26% |
| Operating Income | 8.07M | 26.31M | 95.97M | 81.95M | 38.95M | 39.03M |
| Operating Income Ratio | 0.43% | 1.47% | 5.72% | 5.48% | 2.81% | 3.11% |
| Total Other Income/Expenses | -147.07M | -21.54M | -77.47M | -48.25M | -113.98M | -88.69M |
| Income Before Tax | -139.00M | -663.81M | -113.58M | -51.73M | -75.03M | -49.66M |
| Income Before Tax Ratio | -7.33% | -37.13% | -6.77% | -3.46% | -5.42% | -3.96% |
| Income Tax Expense | -4.47M | -1.78M | 3.47M | 5.32M | 1.49M | -2.51M |
| Net Income | -134.52M | -662.03M | -117.04M | -57.05M | -76.52M | -47.15M |
| Net Income Ratio | -7.10% | -37.03% | -6.97% | -3.82% | -5.53% | -3.76% |
| EPS | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| EPS Diluted | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| Weighted Avg Shares Out | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
| Weighted Avg Shares Out (Dil) | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
Aveanna (AVAH) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Aveanna Announces Third Quarter 2023 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. (AVAH) Q2 2023 Earnings Call Transcript
Aveanna (AVAH) Reports Q2 Earnings: What Key Metrics Have to Say
Aveanna Healthcare (AVAH) Reports Q2 Loss, Tops Revenue Estimates
Aveanna Healthcare Holdings Announces Second Quarter 2023 Financial Results
Aveanna Healthcare Holdings Announces Agreement to Extend its $175 Million Securitization Facility
Aveanna Announces Second Quarter 2023 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2023 Earnings Call Transcript
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports